The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Whole-Genome Sequencing of Methicillin-Resistant Staphylococcus aureus Resistant to Fifth-Generation Cephalosporins Reveals Potential Non-mecA Mechanisms of Resistance
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Substitutions in PBP4 protein (N138K or I, R200L, T201A, F241L, and H270L) determining resistance to ceftobiprole and ceftaroline in MSSA strains were also described [72].”
From Molecular Mechanisms of Drug Resistance in Staphylococcus aureus (2022) · cites this paper as [72]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dantes, R. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.10423 · Cited by 452
Research works printed but not linked: 28
- HW Boucher, 2008, Epidemiology of methicillin-resistant Staphylococcus aureus, Clinical infectious diseases: an official publication of the Infectious Diseases Society of America, 46, S344, 10.1086/533590 · DOI · Paper page
- HF Chambers, 2001, The changing epidemiology of Staphylococcus aureus?, Emerging infectious diseases, 7, 178, 10.3201/eid0702.010204 · DOI · Paper page
- E Beresford, 2014, Ceftaroline fosamil for the treatment of acute bacterial skin and skin structure infections, Expert review of clinical pharmacology, 7, 123, 10.1586/17512433.2014.884457 · DOI
- GR Corey, 2010, Integrated analysis of CANVAS 1 and 2: phase 3, multicenter, randomized, double-blind studies to evaluate the safety and efficacy of ceftaroline versus vancomycin plus aztreonam in complicated skin and skin-structure infection, Clinical infectious diseases: an official publication of the Infectious Diseases Society of America, 51, 641, 10.1086/655827 · DOI · Paper page
- TM File Jr, 2010, Integrated analysis of FOCUS 1 and FOCUS 2: randomized, doubled-blinded, multicenter phase 3 trials of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in patients with community-acquired pneumonia, Clinical infectious diseases: an official publication of the Infectious Diseases Society of America, 51, 1395, 10.1086/657313 · DOI · Paper page
- RA Alm, 2014, Analysis of Staphylococcus aureus clinical isolates with reduced susceptibility to ceftaroline: an epidemiological and structural perspective, The Journal of antimicrobial chemotherapy, 69, 2065, 10.1093/jac/dku114 · DOI
- DJ Biedenbach, 2015, In Vitro Activity of Ceftaroline against Staphylococcus aureus Isolated in 2012 from Asia-Pacific Countries: AWARE Surveillance Program, Antimicrobial agents and chemotherapy
- RN Jones, 2010, Ceftaroline activity against pathogens associated with complicated skin and skin structure infections: results from an international surveillance study, The Journal of antimicrobial chemotherapy, 65, iv17
- LC Chan, 2015, Ceftobiprole- and ceftaroline-resistant methicillin-resistant Staphylococcus aureus, Antimicrobial agents and chemotherapy, 59, 2960, 10.1128/AAC.05004-14 · doi:10.1128/aac.05004-14
- SW Long, 2014, PBP2a mutations causing high-level Ceftaroline resistance in clinical methicillin-resistant Staphylococcus aureus isolates, Antimicrobial agents and chemotherapy, 58, 6668, 10.1128/AAC.03622-14 · DOI
- R Banerjee, 2008, In vitro selection and characterization of ceftobiprole-resistant methicillin-resistant Staphylococcus aureus, Antimicrobial agents and chemotherapy, 52, 2089, 10.1128/AAC.01403-07 · DOI
- R Banerjee, 2010, A mecA-negative strain of methicillin-resistant Staphylococcus aureus with high-level beta-lactam resistance contains mutations in three genes, Antimicrobial agents and chemotherapy, 54, 4900, 10.1128/AAC.00594-10 · DOI · Paper page
- M Martin, 2011, Cutadapt removes adapter sequences from high-throughput sequencing reads, EMBnetjournal, 17
- M Kearse, 2012, Geneious Basic: an integrated and extendable desktop software platform for the organization and analysis of sequence data, Bioinformatics, 28, 1647, 10.1093/bioinformatics/bts199 · DOI · Paper page
- P Macheboeuf, 2006, Penicillin binding proteins: key players in bacterial cell cycle and drug resistance processes, FEMS Microbiol Rev, 30, 673, 10.1111/j.1574-6976.2006.00024.x · DOI · Paper page
- A Zapun, 2008, Penicillin-binding proteins and beta-lactam resistance, FEMS Microbiol Rev, 32, 361, 10.1111/j.1574-6976.2007.00095.x · DOI · Paper page
- TA Leski, 2005, Role of penicillin-binding protein 2 (PBP2) in the antibiotic susceptibility and cell wall cross-linking of Staphylococcus aureus: evidence for the cooperative functioning of PBP2, PBP4, and PBP2A, Journal of bacteriology, 187, 1815, 10.1128/JB.187.5.1815-1824.2005 · DOI · Paper page
- AK Das, 1996, Crystal structure of the protein serine/threonine phosphatase 2C at 2.0 A resolution, The EMBO journal, 15, 6798, 10.1002/j.1460-2075.1996.tb01071.x · DOI · Paper page
- K Kosowska-Shick, 2010, Affinity of ceftaroline and other beta-lactams for penicillin-binding proteins from Staphylococcus aureus and Streptococcus pneumoniae, Antimicrobial agents and chemotherapy, 54, 1670, 10.1128/AAC.00019-10 · DOI · Paper page
- RE Mendes, 2012, Characterization of methicillin-resistant Staphylococcus aureus strains recovered from a phase IV clinical trial for linezolid versus vancomycin for treatment of nosocomial pneumonia, Journal of clinical microbiology, 50, 3694, 10.1128/JCM.02024-12 · DOI
- H Moisan, 2010, Binding of ceftaroline to penicillin-binding proteins of Staphylococcus aureus and Streptococcus pneumoniae, The Journal of antimicrobial chemotherapy, 65, 713, 10.1093/jac/dkp503 · DOI
- G Memmi, 2008, Staphylococcus aureus PBP4 is essential for beta-lactam resistance in community-acquired methicillin-resistant strains, Antimicrobial agents and chemotherapy, 52, 3955, 10.1128/AAC.00049-08 · DOI · Paper page
- UU Henze, 1996, Penicillin-binding protein 4 overproduction increases beta-lactam resistance in Staphylococcus aureus, Antimicrobial agents and chemotherapy, 40, 2121, 10.1128/AAC.40.9.2121 · doi:10.1128/aac.40.9.2121
- K Kumar, 2014, In silico study of penicillin derivatives and cephalosporins for upper respiratory tract bacterial pathogens, 3 Biotech, 4, 241, 10.1007/s13205-013-0147-z · doi:10.1007/s13205-013-0147-z
- KT Baek, 2014, beta-Lactam resistance in methicillin-resistant Staphylococcus aureus USA300 is increased by inactivation of the ClpXP protease, Antimicrobial agents and chemotherapy, 58, 4593, 10.1128/AAC.02802-14 · DOI
- YH Lee, 2014, Mutations in the primary sigma factor sigmaA and termination factor rho that reduce susceptibility to cell wall antibiotics, Journal of bacteriology, 196, 3700, 10.1128/JB.02022-14 · DOI
- CJ Kristich, 2011, Reciprocal regulation of cephalosporin resistance in Enterococcus faecalis, mBio, 2, e00199, 10.1128/mBio.00199-11 · DOI
- V Navratna, 2010, Molecular basis for the role of Staphylococcus aureus penicillin binding protein 4 in antimicrobial resistance, Journal of bacteriology, 192, 134, 10.1128/JB.00822-09 · doi:10.1128/jb.00822-09
Cited by
Molecular Mechanisms of Drug Resistance in Staphylococcus aureus
Mlynarczyk-Bonikowska, B., Kowalewski, C., Krolak-Ulinska, A., & Marusza, W. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158088 · Cited by 412
Metadata
- Authors
- Greninger, A. L., Chatterjee, S. S., Chan, L. C., Hamilton, S. M., Chambers, H. F., & Chiu, C. Y.
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2016-02-18
- Volume
- 11
- Issue
- 2
- Pages
- e0149541
- ISSN
- 1932-6203
- Cited by
- 66
- References
- 1
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Whole-Genome Sequencing of Methicillin-Resistant Staphylococcus aureus Resistant to Fifth-Generation Cephalosporins Reveals Potential Non-mecA Mechanisms of Resistance. https://app.cochat.ai/papers/10.1371/journal.pone.0149541
- The paper
- Greninger, A. L., Chatterjee, S. S., Chan, L. C., Hamilton, S. M., Chambers, H. F., & Chiu, C. Y. (2016). Whole-Genome Sequencing of Methicillin-Resistant Staphylococcus aureus Resistant to Fifth-Generation Cephalosporins Reveals Potential Non-mecA Mechanisms of Resistance. PLOS ONE. https://doi.org/10.1371/journal.pone.0149541
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.